U.S. Forces New Drug Giant to Share Genetic Research

Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

U.S. Forces New Drug Giant to Share Genetic Research

Wall Street Journal (12/18/96) P. B4
Wilke, John R.

Abstract: In an attempt to keep the new drug giant Novartis from dominating gene therapy research, the Federal Trade Commission has mandated that the merging companies Ciba-Geigy and Sandoz share research developments with rivals. Although gene therapy holds the potential to improve treatment of many types of diseases, including cancer, AIDS, and genetic diseases, the technology is still in early stages of development. However, the government conditions will not have a serious financial impact on Novartis, which expects to report annual sales of $27 billion. William Haseltine, CEO of Human Genome Science, noted that the action will help ensure "that a fundamental medical breakthrough with enormous commercial promise will be available" to competing researchers.

961218
AD962397

Copyright © 1996 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.